Lumasiran
Catalog No.
BA4979
Lumasiran (ALN-G01) is an siRNA compound that reduces hepatic oxalate production by targeting glycolic acid oxidase.
Featured Products
Lumasiran (ALN-G01) is an siRNA compound that reduces hepatic oxalate production by targeting the enzyme ethanolic acid oxidase.Lumasiran inhibits oxalate synthesis by silencing the gene encoding the enzyme ethanolic acid oxidase and depleting the enzyme oxalate oxidase, a toxic metabolite directly associated with the manifestation of primary hyperoxaluria type 1 (PH1).
| Physical Appearance | A solid |
| Storage | Tightly sealed and desiccated at -20°C |
| M.Wt | 16339.00(AS:7631.0+SS:8708.0) |
| Cas No. | 1834610-13-7 |
| Synonyms | ALN-G01 |
| Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
| General tips | We do not recommend long-term storage for the solution, please use it up soon. |